Company intelligence / Profile preview

Ghost Tree Capital

New York, New York, United Statespreqin.com ↗

Ownership: Private
Development stage: Other

Overview

Ghost Tree Capital does not conduct clinical research or have its own clinical results. It specializes in long/short equity strategies focused on the healthcare industry, identifying undervalued opportunities through fundamental analysis and maintaining a diversified portfolio to mitigate risk[3][7].

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships reported; operates independently as an investment manager.

Beyond the preview

Go deeper on Ghost Tree Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ghost Tree Capital.

Explore the full profile